Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -496.55x is 322% below its 1-year average of -117.54x, near the low end of its 1-year range (-496.55x–-18.65x).
Reported quarterly interest coverage; no daily interpolation. Q3 FY2025 (2025-09-30): -232.60x.
INTEREST COVERAGE RATIO
-496.55x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.13x
median of 332 covered companies
CURRENT VS SECTOR MEDIAN
-11908.46%
vs the sector median at left
Curanex Pharmaceuticals Inc Common Stock
Market Cap
$7.21M
Interest Coverage Ratio
-496.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.00M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.85M
Interest Coverage Ratio
-82777.81x
TTM Avg
11.97x
3Y Avg
11.97x
5Y Avg
11.97x
Market Cap
$7.58M
Interest Coverage Ratio
-924.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.72M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.89M
Interest Coverage Ratio
-1049.68x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Curanex Pharmaceuticals Inc Common Stock (CURX) | $7.21M | -496.55x | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $7.00M | N/A | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.85M | -82777.81x | 11.97x | 11.97x | 11.97x |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.58M | -924.78x | N/A | N/A | N/A |
| Longeveron Inc. (LGVN)vs › | $7.61M | N/A | N/A | N/A | N/A |
| Aclarion, Inc. (ACON)vs › | $6.80M | N/A | N/A | N/A | N/A |
| KALA BIO, Inc. (KALA)vs › | $6.77M | -11.95x | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | N/A | N/A | N/A | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.89M | -1049.68x | N/A | N/A | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $7.96M | -97.81x | N/A | N/A | N/A |
Interest Coverage
-496.6x
Debt/Equity
0.06
Current Ratio
45.95
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-09-30 | -232.60x |
| 2025-06-30 | -18.65x |
| 2025-03-31 | -101.37x |
